<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01063491</url>
  </required_header>
  <id_info>
    <org_study_id>10-001</org_study_id>
    <nct_id>NCT01063491</nct_id>
  </id_info>
  <brief_title>Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study</brief_title>
  <acronym>CABG-PRO</acronym>
  <official_title>Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Texas Veterans Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Texas Veterans Healthcare System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aortocoronary bypass graft failure is common and is associated with high morbidity and&#xD;
      mortality. Failure of saphenous vein grafts is more common than failure of internal mammary&#xD;
      artery grafts. Whether early graft angiography can reduce bypass graft failure remains&#xD;
      unknown. The Cardiac CAtheterization for Bypass Graft Patency Rate Optimization (CABG-PRO)&#xD;
      randomized-controlled pilot study is a phase III, double-blind, randomized-controlled pilot&#xD;
      trial that will randomize 170 patients undergoing coronary artery bypass graft surgery to&#xD;
      early (before dismissal) graft angiography vs. no early graft angiography. Coronary&#xD;
      angiography will be performed at 12 months, to determine whether compared to no early graft&#xD;
      angiography, early graft angiography will result in:&#xD;
&#xD;
        1. lower per patient angiographic bypass graft failure (in at least one graft) rates&#xD;
           (defined as ≥75% diameter stenosis in at least one bypass graft) (primary efficacy&#xD;
           endpoint)&#xD;
&#xD;
        2. lower per graft failure rates, per graft occlusion rates, and per patient bypass graft&#xD;
           occlusion rates (in at least one bypass graft) (secondary endpoints)&#xD;
&#xD;
        3. lower incidence major adverse cardiac events (death, nonfatal myocardial infarction,&#xD;
           nonfatal stroke, coronary revascularization, and composite of death/myocardial&#xD;
           infarction) (secondary endpoint)&#xD;
&#xD;
      Intravascular ultrasonography and near-infrared spectroscopy will also be performed in at&#xD;
      least one bypass graft at baseline (in the early graft angiography group only) and at&#xD;
      12-month angiographic follow-up to evaluate the structural bypass graft changes occurring&#xD;
      after coronary artery bypass graft surgery (secondary endpoint).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Per patient bypass graft failure (defined as ≥75% graft diameter stenosis) in at least one bypass graft, as assessed by quantitative coronary angiography performed at 12 months.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Per graft incidence of bypass graft failure; per graft incidence of bypass graft occlusion; and per patient incidence of at least one bypass graft occlusion</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events (death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, and composite of death/myocardial infarction)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean SVG lumen diameter and wall thickness, as assessed by intravascular ultrasonography and mean lipid core burden index, as assessed by near-infrared intracoronary spectroscopy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Coronary Artery Bypass Graft Surgery</condition>
  <arm_group>
    <arm_group_label>Early graft angiography after coronary artery bypass surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of any bypass graft abnormalities that are discovered will be performed if needed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No early angiography after coronary artery bypass surgery</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bypass graft angiography</intervention_name>
    <arm_group_label>Early graft angiography after coronary artery bypass surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;18 years&#xD;
&#xD;
          2. Willing and able to give informed consent. The patients must be able to comply with&#xD;
             study procedures and follow-up.&#xD;
&#xD;
          3. Undergoing clinically-indicated coronary artery bypass graft surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Positive pregnancy test or breast-feeding&#xD;
&#xD;
          2. Coexisting conditions that limit life expectancy to less than 12 months or that could&#xD;
             affect a patient's compliance with the protocol&#xD;
&#xD;
          3. Serum creatinine &gt; 2.5 mg/dL or acute renal failure&#xD;
&#xD;
          4. Severe peripheral arterial disease limiting vascular access&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>VA North Texas Healthcare System</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <study_first_submitted>February 4, 2010</study_first_submitted>
  <study_first_submitted_qc>February 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2010</study_first_posted>
  <last_update_submitted>October 31, 2013</last_update_submitted>
  <last_update_submitted_qc>October 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Texas Veterans Healthcare System</investigator_affiliation>
    <investigator_full_name>Emmanouil Brilakis</investigator_full_name>
    <investigator_title>Director, Cardiac Catheterization Laboratories</investigator_title>
  </responsible_party>
  <keyword>coronary artery bypass graft surgery</keyword>
  <keyword>bypass grafts</keyword>
  <keyword>angiography</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>coronary imaging</keyword>
  <keyword>coronary artery bypass graft surgery, bypass graft patency</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

